Edward Tenthoff
Stock Analyst at Piper Sandler
(4.39)
# 1,251
Out of 5,020 analysts
1272
Total ratings
39.2%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines | Reiterated: Buy | $24 → $26 | $13.80 | +88.41% | 4 | Oct 2, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $37 | $11.26 | +228.60% | 20 | Oct 2, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $15 | $3.84 | +290.63% | 15 | Sep 29, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $47 | $15.82 | +197.09% | 26 | Sep 29, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $12 | $2.63 | +356.27% | 11 | Sep 23, 2026 | |
| ARVN Arvinas | Reiterated: Buy | $20 | $7.43 | +169.18% | 34 | Sep 14, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $12 | $9.28 | +29.31% | 8 | Sep 8, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $2 → $25 | $8.94 | +179.64% | 17 | Sep 1, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $489 | $231.18 | +111.52% | 101 | Aug 31, 2026 | |
| MESO Mesoblast | Reiterated: Buy | $35 → $39 | $14.32 | +172.35% | 16 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.30 | +438.46% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $2.30 | +247.83% | 38 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.01 | +298.01% | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.21 | +230.58% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.18 | +408.47% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $188.94 | -59.25% | 112 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $24.77 | +33.23% | 47 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $64.79 | +94.47% | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $55.44 | +98.41% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $7 | $0.8668 | +707.57% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.57 | +91.08% | 30 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 | $19.32 | +231.26% | 23 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.96 | +202.42% | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.61 | +148.45% | 21 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $23 → $3 | $3.67 | -18.26% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.8157 | +758.16% | 19 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 → $48 | $1.60 | +2,900.00% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $2.93 | +582.59% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $110.12 | +13.51% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $15.97 | +25.23% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $25.25 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.8061 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $2.83 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0004 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $3.56 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $13.32 | n/a | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $13 | $0.2941 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.000001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $89.93 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $44 | $14.39 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $13 | $1.76 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $60 | $15.43 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $506.74 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $9 | $1.11 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $40 | $65.62 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $57.94 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $309 → $250 | $936.00 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $2.42 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $1.05 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $147.50 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $3.06 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $17.57 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $12.73 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $10.60 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.00001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $19 | $39.44 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $0.152 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.0001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $5 | $0.0001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $734.81 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.2075 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $5.05 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $84.13 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $44.00 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.6412 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.8307 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $11.33 | n/a | 1 | Dec 31, 2012 |
Generate Biomedicines
Oct 2, 2026
Reiterated: Buy
Price Target: $24 → $26
Current: $13.80
Upside: +88.41%
Monte Rosa Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $37
Current: $11.26
Upside: +228.60%
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $15
Current: $3.84
Upside: +290.63%
Dyne Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $47
Current: $15.82
Upside: +197.09%
CytomX Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $12
Current: $2.63
Upside: +356.27%
Arvinas
Sep 14, 2026
Reiterated: Buy
Price Target: $20
Current: $7.43
Upside: +169.18%
ImmunityBio
Sep 8, 2026
Reiterated: Buy
Price Target: $12
Current: $9.28
Upside: +29.31%
Capricor Therapeutics
Sep 1, 2026
Upgraded: Buy
Price Target: $2 → $25
Current: $8.94
Upside: +179.64%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $489
Current: $231.18
Upside: +111.52%
Mesoblast
Aug 27, 2026
Reiterated: Buy
Price Target: $35 → $39
Current: $14.32
Upside: +172.35%
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $1.30
Upside: +438.46%
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $2.30
Upside: +247.83%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $2.01
Upside: +298.01%
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
Aug 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.18
Upside: +408.47%
Aug 6, 2026
Reiterated: Buy
Price Target: $77
Current: $188.94
Upside: -59.25%
Aug 6, 2026
Reiterated: Buy
Price Target: $33
Current: $24.77
Upside: +33.23%
Aug 5, 2026
Reiterated: Buy
Price Target: $126
Current: $64.79
Upside: +94.47%
Aug 4, 2026
Reiterated: Buy
Price Target: $110
Current: $55.44
Upside: +98.41%
Jul 31, 2026
Reiterated: Buy
Price Target: $16 → $7
Current: $0.8668
Upside: +707.57%
Jul 28, 2026
Reiterated: Buy
Price Target: $3
Current: $1.57
Upside: +91.08%
Jun 15, 2026
Reiterated: Buy
Price Target: $64
Current: $19.32
Upside: +231.26%
Jun 10, 2026
Reiterated: Buy
Price Target: $15
Current: $4.96
Upside: +202.42%
Jun 9, 2026
Reiterated: Buy
Price Target: $4
Current: $1.61
Upside: +148.45%
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.67
Upside: -18.26%
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $0.8157
Upside: +758.16%
May 12, 2026
Rated: Buy
Price Target: $104 → $48
Current: $1.60
Upside: +2,900.00%
Feb 13, 2026
Reiterated: Hold
Price Target: $20
Current: $2.93
Upside: +582.59%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $110.12
Upside: +13.51%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $15.97
Upside: +25.23%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $25.25
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $0.8061
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $2.83
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0004
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $3.56
Upside: n/a
Aug 17, 2023
Reiterated: Hold
Price Target: $0.5
Current: $13.32
Upside: n/a
Apr 11, 2023
Reiterated: Buy
Price Target: $9 → $13
Current: $0.2941
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.000001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $89.93
Upside: n/a
Aug 25, 2022
Reiterated: Buy
Price Target: $37 → $44
Current: $14.39
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $20 → $13
Current: $1.76
Upside: n/a
May 23, 2022
Reiterated: Buy
Price Target: $160 → $60
Current: $15.43
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $323
Current: $506.74
Upside: n/a
Sep 20, 2021
Reiterated: Buy
Price Target: $7 → $9
Current: $1.11
Upside: n/a
Aug 8, 2021
Reiterated: Buy
Price Target: $42 → $40
Current: $65.62
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $36
Current: $57.94
Upside: n/a
Jun 7, 2021
Reiterated: Hold
Price Target: $309 → $250
Current: $936.00
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $2.42
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $1.05
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $147.50
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $3.06
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $17.57
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $12.73
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $10.60
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.00001
Upside: n/a
Nov 6, 2018
Reiterated: Buy
Price Target: $16 → $19
Current: $39.44
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $0.152
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.0001
Upside: n/a
Nov 2, 2017
Reiterated: Buy
Price Target: $17 → $5
Current: $0.0001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $734.81
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $0.2075
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $5.05
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $84.13
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $44.00
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.6412
Upside: n/a
Feb 20, 2013
Reiterated: Buy
Price Target: $6
Current: $0.8307
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $11.33
Upside: n/a